Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Aaron S. Cote"'
Autor:
Nandkishor K. Nere, Daniel Patience, Aaron S. Cote, Yiqing Claire Liu, Moussa Boukerche, Iben Østergaard, Daniel Pohlman, Eric B. Sirota, Daniel A. Green, Kushal Sinha, Justin L. Quon, Ryan Ellis, Jaron Mackey, Daniel J. Jarmer, Botond Szilagyi, Michael A. Lovette, Huayu Li, Ayse Eren, Zoltan K. Nagy, Wei-Lee Wu, Rahn McKeown, Lorenzo Codan, Erwin Irdam, Shivani Kshirsagar, Kevin P. Girard, Megan Ketchum, Yihui Yang, Haiyan Qu, Christopher S. Polster, Jie Chen, Venkata Ramana Reddy, Emoke Szilagyi, Samir A. Kulkarni, Anna Jawor-Baczynska, Akshay Korde, Laurie Mlinar, Bing-Shiou Yang, Jochen Schoell, Christopher L. Burcham, Jeremy M. Merritt, Simon N. Black
Publikováno v:
Szilagyi, B, Wu, W-L, Eren, A, Mackey, J, Kshirsagar, S, Szilagyi, E, Østergaard, I, Qu, H, Sinha, K, Mlinar, L, Pohlman, D, Chen, J, Nere, N, Boukerche, M, Korde, A, Ellis, R, Lovette, M, Black, S, Jawor-Baczynska, A, Li, H, Yang, B-S, Irdam, E, Patience, D, McKeown, R, Ketchum, M, Green, D A, Reddy, V R, Polster, C, Burcham, C, Jarmer, D, Merritt, J M, Cote, A, Sirota, E, Codan, L, Schoell, J, Liu, Y C, Girard, K P, Kulkarni, S A, Yang, Y, Quon, J L & Nagy, Z K 2021, ' Cross-pharma collaboration for the development of a simulation tool for the model-based digital design of pharmaceutical crystallization processes (CrySiV) ', Crystal Growth & Design, vol. 21, no. 11, pp. 6448-6464 . https://doi.org/10.1021/acs.cgd.1c00904
Precompetitive collaborations on new enabling technologies for research and development are becoming popular among pharmaceutical companies. The Enabling Technologies Consortium (ETC), a precompetitive collaboration of leading innovative pharmaceutic
Autor:
Anne E. Mohan, Aaron S. Cote, Eric Khong, Keith A. Mattern, Michael Whittington, Kevin M. Maloney, Eric B. Sirota, Yee Swan Ang, Michael DiBenedetto, Anthony Diaz-Santana, Richard Desmond, Ivan H. Lee, Beata Tao, Muhammad Sofian Bin Asi Sihombing, Christopher Pridgen, Glenn Spencer, Hsieh Yao D. Chang, Kevin M. Sirk, Hong Ren, Si-Wei Zhang, Wenjun Liu, Embarek Alwedi, Cuixian Yang
Publikováno v:
Organic Process Research & Development. 25:541-551
The final chemical transformation and isolation in the synthesis of an active pharmaceutical ingredient (API), referred to as the Pure Step, is often chemically simple but scientifically, operation...
Autor:
Nandkishor K. Nere, Aaron S. Cote, Michael A. Lovette, Kevin P. Girard, Eric B. Sirota, Daniel Albert Green, Deniz Erdemir
Publikováno v:
Crystal Growth & Design. 20:7568-7581
Crystallization is the primary process used to purify synthetic drug substances and intermediates as well as to control bulk properties, including particle size, surface area, and flowability. Acco...
Publikováno v:
Organic Process Research & Development. 24:2639-2650
For drug substance manufacturing, it is necessary to have a robust crystallization process that can isolate quality active pharmaceutical ingredients with the desired crystal size distribution (CSD...
Autor:
Aaron S. Cote, Andre Hermans, Zhen Liu, Siwei Zhang, Jie Ren, Amanda K. P. Mann, Luke Schenck, Mikolaj Milewski, Kristel Dewitt
Publikováno v:
International Journal of Pharmaceutics. 559:147-155
Amorphous solid dispersions are a promising option for managing compounds with poor aqueous solubility. However, for compounds with high melting points, thermal stability limitations, or poor solubility in volatile solvents, conventional routes of ho
Publikováno v:
Drug Development and Industrial Pharmacy. 45:521-531
Direct compression offers a simple route to generate pharmaceutical dosage units and is core to the growing arena of continuous manufacturing. However, direct compression can be untenable for some active materials. This paper will outline three speci
Publikováno v:
Organic Process Research & Development. 22:1131-1142
A shift in particle size distribution toward smaller particle sizes has been observed in batches of Compound A Triethanolate, an isolated intermediate of a commercially available active pharmaceutical ingredient, leading to poor deliquoring of the fi
Autor:
Erwin Irdam, Christopher J. Welch, Aaron S. Cote, Jean W. Tom, Pierre Boulas, Joel M. Hawkins, Kenneth M. Wells, Charles D. Papageorgiou, David Dermot Patrick Laffan, Margaret M. Faul, Purdie Mark, Rahn McKeown, Scott A. May, Steven J. Wittenberger, Srinivas Tummala, Kevin D. Seibert, Nicholas Murray Thomson, Frederick Hicks, Antonio Christian Ferretti, Paul Frank Fernandez, Keith Horspool, Shailendra Bordawekar, Bing-Shiou Yang
Publikováno v:
Organic Process Research & Development. 21:414-419
The creation of the Enabling Technologies Consortium (ETC) is described. The ETC fosters precompetitive collaborations aimed at the development and evaluation of new enabling technologies for pharmaceutical research and development, with an initial f
Autor:
Lorenzo Codan, Eric B. Sirota, Jochen Schoell, Roberto Irizarry, Cameron Mengel, Aaron S. Cote
Publikováno v:
AIChE Journal. 65:e16560
Publikováno v:
Organic Process Research & Development. 17:1335-1344
Rotor–stator wet mills are commonly used in the pharmaceutical industry to reduce particle size and normalize API physical properties as a means to facilitate downstream drug product operations and...